Skip to main navigation Skip to search Skip to main content

The enigma of parkinsonism in chronic borderline mercury intoxication, resolved by challenge with penicillamine

  • Y. Finkelstein
  • , J. Vardi
  • , M. M. Kesten
  • , I. Hod*
  • *Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

17 Scopus citations

Abstract

A 47 year old female dentist suffered from hemiparkinsonism which had started eighteen months earlier and was manifested mainly by resting tremor and cogwheel rigidity. A baseline quantitative urinary mercury excretion was 46 μg/day. The patient was treated with chelating agent d-penicillamine for a week. Chelation therapy resulted in clinical improvement of parkinsonism and in dynamic changes in daily urinary mercury excretion with a prompt increase to 79 μg/day, a subsequent decline followed by increase in the mercury urinary excretion. After a week chelation therapy was stopped. During a follow-up period of five years, the neurological status remained unChanged after the initial penicillamine-induced improvement. This case may be evidence, therefore, of a rare clinical variant of elemental mercury intoxication associated with parkinsonism, in the absence of most classical neuropsychiatric signs of chronic mercurialism.

Original languageEnglish
Pages (from-to)291-296
Number of pages6
JournalNeuroToxicology
Volume17
Issue number1
StatePublished - 1996

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Dentist
  • Mercury Poisoning
  • Parkinson's Disease
  • Penicillamine

Fingerprint

Dive into the research topics of 'The enigma of parkinsonism in chronic borderline mercury intoxication, resolved by challenge with penicillamine'. Together they form a unique fingerprint.

Cite this